Frontiers in oncology

Front Oncol · ISSN (print) 2234-943X · 361 papers in corpus
lab-animal 2020
doi:10.3389/fonc.2020.618472 ·PMID:33680939

RESEARCH QUESTION: The expression of the long noncoding RNA (lncRNA) urothelial carcinoma-associated 1 (UCA1) in embryonic tissues is higher than that in most cancer tissues, such as bladder cancer, indicating that RNA is a carcinoembryonic…

review 2020
doi:10.3389/fonc.2020.00361 ·PMID:32269964

Every cancer carries genomic mutations. Although almost all these mutations arise after fertilization, a minimal count of cancer predisposition mutations are already present at the time of genesis of germ cells. Of the cancer predisposition…

review 2020
doi:10.3389/fonc.2020.00163 ·PMID:32133297

Ovarian cancer is the most lethal malignancy among gynecological cancers worldwide. Most ovarian cancer patients are diagnosed at an advanced stage because of non-specific clinical symptoms. The human microbiome plays a crucial role in main…

observational 2020
doi:10.3389/fonc.2020.01353 ·PMID:32850433

Introduction: The International Federation of Gynecology and Obstetrics (FIGO) staging system is considered the most powerful prognostic factor in patients with cervical cancer. In addition, other surgical-pathological risk factors have bee…

case-report 2020
doi:10.3389/fonc.2020.523989 ·PMID:33384952

Serous endometrial cancer (SEC) and high grade serous ovarian cancer (HGSOC) are aggressive gynecological malignancies with high rates of metastasis and poor prognosis. Endometrial intraepithelial carcinoma (EIC), the precursor for SEC, and…

review 2020
doi:10.3389/fonc.2020.01370 ·PMID:32850438

Endometriosis is a disorder characterized by the presence of endometrial glands and stroma like lesions outside of the uterus. Although several hypothesis have tried to explain the underlying cause of endometriosis, yet the main cause remai…

review 2020
doi:10.3389/fonc.2020.01084 ·PMID:32850313

Ovarian cancer is one of the top gynecological malignancies that cause deaths among females in the United States. At the molecular level, significant progress has been made in our understanding of ovarian cancer development and progression.…

lab-animal 2020
doi:10.3389/fonc.2020.00209 ·PMID:32175276

Ovarian cancer is estimated to reach 22,530 diagnoses and cause 13,980 cancer deaths per year. The most common histology diagnosed of ovarian cancer is epithelial ovarian carcinomas (EOC). An aggressive epithelial subtype is clear cell ovar…

review 2020
doi:10.3389/fonc.2020.566511 ·PMID:33194645

Tumor-associated macrophages (TAMs) are major innate immune cells that constitute up to 50% of the cell mass of human tumors. TAMs are highly heterogeneous cells that originate from resident tissue-specific macrophages and from newly recrui…

other 2020
doi:10.3389/fonc.2020.00538 ·PMID:32351899

Mullerian adenosarcoma (MAS) is a biphasic tumor with malignant stroma. It is most commonly of endometrial origin but occasionally originates in the cervix, ovary, or other pelvic/peritoneal sites. The typical MAS is low grade with an indol…

diagnostic-accuracy 2019
doi:10.3389/fonc.2019.00067 ·PMID:30838173

Recently, the research on early detection of precancerous change and endometrial carcinoma has been focusing on minimally invasive procedures for screening. On this basis, we aim to verify the feasibility of endometrial samplers for screeni…

review 2019
doi:10.3389/fonc.2019.00913 ·PMID:31608227

Angiogenesis, or generation of new blood vessels from other pre-existing, is a key process to maintain the supply of nutrients and oxygen in tissues. Unfortunately, this process is exacerbated in pathologies such as retinopathies and cancer…

case-report 2019
doi:10.3389/fonc.2019.01252 ·PMID:31824845

Endometriosis is one of the most common benign gynecological diseases. It shows similar attributes to those of some fatal tumors if it is becomes malignant. These attributes include invasion, implantation, and recurrence. Epidemiological, c…

lab-animal 2019
doi:10.3389/fonc.2019.01195 ·PMID:31781497

Huaier, as known as Trametes robiniophila Murr, is a traditional Chinese medicine. Various studies have demonstrated that Huaier could inhibit cancer progression and improve the prognosis of patients. In the present study, we comprehensivel…

review 2019
doi:10.3389/fonc.2019.00421 ·PMID:31192126

Ovarian cancer is the most lethal gynecological malignancy worldwide. Most patients are diagnosed at late stages because of atypical symptoms and the lack of effective early diagnostic measures. The mechanisms underlying the oncogenesis and…

other 2019
doi:10.3389/fonc.2019.01150 ·PMID:31737572

A central reason behind the poor clinical outcome of patients with high-grade serous carcinoma (HGSC) of the ovary is the difficulty in reliably detecting early occurrence or recurrence of this malignancy. Biomarkers that provide reliable d…

lab-animal 2019
doi:10.3389/fonc.2019.01570 ·PMID:32083017

Ovarian Clear Cell Carcinoma (OCCC) displays distinctive clinical and molecular characteristics and confers the worst prognosis among all ovarian carcinoma histotypes when diagnosed at advanced stage, because of the lack of effective therap…

review 2019
doi:10.3389/fonc.2019.01370 ·PMID:31921634

During angiogenesis, new vessels emerge from existing endothelial lined vessels to promote the degradation of the vascular basement membrane and remodel the extracellular matrix (ECM), followed by endothelial cell migration, and proliferati…

review 2019
doi:10.3389/fonc.2019.00344 ·PMID:31157162

Telomeres at the termini of human chromosomes are shortened with each round of cell division due to the "end replication problem" as well as oxidative stress. During carcinogenesis, cells acquire or retain mechanisms to maintain telomeres t…

review 2019
doi:10.3389/fonc.2019.00943 ·PMID:31632902

Although significant progress has been made in the implementation of new breast cancer treatments over the last three decades, this neoplasm annually continues to show high worldwide rates of morbidity and mortality. In consequence, the sea…

review 2018
doi:10.3389/fonc.2018.00654 ·PMID:30627526

The dualistic classification of epithelial ovarian cancer (EOC) into "type I" and "type II" is widely applied in the research setting; it is used as a convenient way of conceptualizing different mechanisms of tumorigenesis. However, this cl…

review 2017
doi:10.3389/fonc.2017.00145 ·PMID:28725636

Epithelial-to-mesenchymal transition (EMT) is a physiological process that is vital throughout the human lifespan. In addition to contributing to the development of various tissues within the growing embryo, EMT is also responsible for woun…

other 2017
doi:10.3389/fonc.2017.00109 ·PMID:28611940

OBJECTIVE: Ovarian clear cell carcinomas (OCCCs) constitute a rare ovarian cancer subtype with distinct clinical features, but may nonetheless be difficult to distinguish morphologically from other subtypes. There is limited knowledge of ge…

case-report 2016
doi:10.3389/fonc.2016.00190 ·PMID:27610354

INTRODUCTION: A 51 year-old woman was diagnosed with endometrial cancer (EC) and underwent surgical staging. Pathological evaluation showed a 2 cm × 1 cm G2 endometrioid EC with a 30% myometrial deep invasion (FIGO Stage 1A). The patient wa…

review 2016
doi:10.3389/fonc.2016.00108 ·PMID:27200296

High-grade serous carcinoma (HGSC) is the most common and aggressive histotype of epithelial ovarian cancer (EOC), and it is the predominant histotype associated with hereditary breast and ovarian cancer syndrome (HBOC). Mutations in BRCA1 …